Parathyroid hormone and corticosteroid-induced osteoporosis [10]

Lancet

Volumn 352, Issue 9144, 1998, Pages 1940-

  Manolagas, S C ^a   Weinstein, R S ^a   Jilka, R L ^a   Parfitt, A M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PARATHYROID HORMONE;

ANIMAL CELL; APOPTOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; LIFESPAN; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRABECULAR BONE;

EID: 0032512313     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60443-6     Document Type: Letter

References (5)

1. H Wunsch Parathyroid hormone may reverse corticosteroid bone effects Lancet 352 1998 1362
2. NE Lane S Sanchez GW Modin Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis J Clin Invest 102 1998 1627 1633
3. JC Stevenson Management of corticosteroid-induced osteoporosis Lancet 352 1998 1327 1328
4. RS Weinstein RF Jilka AM Parfitt SC Manolagas Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone J Clin Invest 102 1998 274 282
5. RL Jilka RS Weinstein P Roberson PTH increases bone formation by postponing osteoblast apoptosis, not by increasing precursor proliferation Bone 23 1998 S519